RBC Capital on Cytokinetics (CYTK): 'The stock is significantly undervalued despite today's move'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| CYTOKINETICS (NASDAQ: CYTK) | Delayed: 63.31 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.31 | 52 Week High | $13.18 | |||
| Open | $63.31 | 52 Week Low | $6.00 | |||
| Day High | $63.31 | P/E | N/A | |||
| Day Low | $63.31 | EPS | $-1.24 | |||
| Volume | 30 | |||||
